Voyager Therapeutics Inc (VYGR)
EBITDA Growth
-0.73%
TTM · Period ending:
VYGR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-0.73%period ending
Latest reported-0.73%period ending
VYGR TTM EBITDA YoY % (-38.57% → -0.73%)
Year-over-year change
High-resolution chart · PNG
VYGR ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -0.726% | |
| -41.6356% | |
| -93.801% | |
| -483.3187% | |
| -790.1997% | |
| -3,167.8004% | |
| -143.0266% | |
| -44.344% | |
| -85.2123% | |
| -97.5127% | |
| 444.6009% | |
| 696.4446% | |
| 292.3974% | |
| 263.9285% | |
| 42.0142% | |
| 90.3999% | |
| -646.7229% | |
| -308.4227% | |
| -322.2012% | |
| -344.0696% | |
| 115.5422% | |
| 172.8% | |
| 166.4558% | |
| 173.2346% | |
| -3.9844% | |
| 56.4986% | |
| 46.7663% | |
| 28.4844% | |
| 26.2299% | |
| -30.5762% | |
| -25.512% | |
| -8.4959% | |
| -35.6888% | |
| -45.7694% | |
| -72.7105% | |
| -110.1126% | |
| -112.3872% | |
| -126.8485% | |
| -107.0113% | |
| -104.5219% | |
| -69.3156% | |
| -40.1937% | |
| -38.5743% |